|
ZNF669 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.538500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.622800E-04 |
| Normal-vs-Stage2 |
1.200460E-02 |
| Normal-vs-Stage3 |
2.816200E-01 |
| Normal-vs-Stage4 |
1.486000E-02 |
| Stage1-vs-Stage2 |
9.984200E-01 |
| Stage1-vs-Stage3 |
3.132800E-01 |
| Stage1-vs-Stage4 |
5.150600E-01 |
| Stage2-vs-Stage3 |
3.808000E-01 |
| Stage2-vs-Stage4 |
5.766400E-01 |
| Stage3-vs-Stage4 |
3.236200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.071990E-02 |
| Normal-vs-AfricanAmerican |
1.858920E-03 |
| Normal-vs-Asian |
2.716000E-03 |
| Caucasian-vs-AfricanAmerican |
3.206200E-01 |
| Caucasian-vs-Asian |
1.167160E-01 |
| AfricanAmerican-vs-Asian |
1.891650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.420310E-04 |
| Normal-vs-Female |
3.522800E-01 |
| Male-vs-Female |
3.355100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.790000E-02 |
| Normal-vs-Extreme_Weight |
4.12320000000577E-05 |
| Normal-vs-Obese |
5.955500E-03 |
| Normal-vs-Extreme_Obese |
3.023900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.147950E-01 |
| Normal_Weight-vs-Obese |
6.682000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.145600E-01 |
| Extreme_Weight-vs-Obese |
9.899600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.143600E-01 |
| Obese-vs-Extreme_Obese |
5.537000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.228200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.524300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.442870E-03 |
| Normal-vs-Age(81-100Yrs) |
3.759000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.332400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.252400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.959400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.100650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.506410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.384600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.225100E-04 |
| Normal-VS-Type2 PRCC |
2.539700E-02 |
| Normal-VS-KIRP CIMP |
9.379200E-03 |
| Normal-VS-Unclassified PRCC |
6.329700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.199800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.586800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.793200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.198000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.179800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.957380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08329999995538E-06 |
| Normal-vs-N1 |
9.763000E-01 |
| Normal-vs-N2 |
1.178070E-02 |
| N0-vs-N1 |
1.603720E-02 |
| N0-vs-N2 |
4.525200E-01 |
| N1-vs-N2 |
1.663220E-01 |
|
|
